Association of the BANK1 R61H variant with systemic lupus erythematosus in Americans of European and African ancestry
Autor: | F. George Otieno, Struan F.A. Grant, Andrew W. Eckert, Kathleen E. Sullivan, Rosetta M. Chiavacci, Marcin Imielinski, Ryan M. Smith, Julie L. Shaner, Michelle Petri, Hakon Hakonarson, Edward C. Frackelton, Joseph T. Glessner, Erin Santa, Jonathan P. Bradfield, Kiran Annaiah, Cecilia E. Kim |
---|---|
Rok vydání: | 2008 |
Předmět: |
030203 arthritis & rheumatology
0303 health sciences education.field_of_study business.industry Population Locus (genetics) Single-nucleotide polymorphism Genome-wide association study Odds ratio Minor allele frequency 03 medical and health sciences 0302 clinical medicine Immunology Cohort Genetics Medicine SNP business education Genetics (clinical) 030304 developmental biology |
Zdroj: | The Application of Clinical Genetics. 2:1-5 |
ISSN: | 1178-704X |
DOI: | 10.2147/tacg.s4089 |
Popis: | Recently an association was demonstrated between the single nucleotide polymorphism (SNP), rs10516487, within the B-cell gene BANK1 and systemic lupus erythematosus (SLE) as a consequence of a genome wide association study of this disease in European and Argentinean populations. In a bid for replication, we examined the effects of the R61H non-synonymous variant with respect to SLE in our genotyped American cohorts of European and African ancestry. Utilizing data from our ongoing genome-wide association study in our cohort of 178 Caucasian SLE cases and 1808 Caucasian population-based controls plus 148 African American (AA) SLE cases and 1894 AA population-based controls we investigated the association of the previously described non-synonymous SNP at the BANK1 locus with the disease in the two ethnicities separately. Using a Fisher's exact test, the minor allele frequency (MAF) of rs10516487 in the Caucasian cases was 22.6% while it was 31.2% in Caucasian controls, yielding a protective odds ratio (OR) of 0.64 (95% CI 0.49-0.85; one-sided p = 7.07 × 10(-4)). Furthermore, the MAF of rs10516487 in the AA cases was 18.7% while it was 23.3% in AA controls, yielding a protective OR of 0.75 (95% CI 0.55-1.034; one-sided p = 0.039). The OR of the BANK1 variant in our study cohorts is highly comparable with that reported previously in a South American/European SLE case-control cohort (OR = 0.72). As such, R61H in the BANK1 gene confers a similar magnitude of SLE protection, not only in European Americans, but also in African Americans. |
Databáze: | OpenAIRE |
Externí odkaz: |